Polymorphisms in the Tumor Necrosis Factor Receptor Genes Affect the Expression Levels of Membrane-Bound Type I and Type II Receptors
Figure 3
(a) Percentage of CD14+ cells expressing TNFRII in individuals presenting with different SNP TNFRII −3609C/T (rs590368) genotypes. Kruskall-Wallis test, , Mann-Whitney test: CC versus CT, . (b) Number of membrane-bound TNFRII present on CD14+ monocytes in individuals presenting with different SNP TNFRII −3609C/T (rs590368) genotypes.